IAG’ Strengthens its Clinical Trial Operations Team
IAG, Image Analysis Group announced today the expansion of its Clinical Trial Operations team and welcomed Michael Clark, VP of Business and Clinical Trial Operations and Sébastien Jacques, Sn Project Manager Oncology Clinical Research.
Sébastien Jacques, MSc, MPM is an experienced project manager with a demonstrated history of working in the pharmaceuticals industry and a technical expert with background in software engineering and information technology. He brings 12+ years of experience in program & portfolio management of global multicentre trials in solid tumours, bladder, BTC, cholangiocarcinoma, HCC, NSCLC, pancreatic adenocarcinoma and other oncology indications. Sebastien will join IAG’s team to support our biotech and pharma customers’ clinical development projects.
Michael Clark, will be taking a leadership management role and oversee the strategic planning and execution of clinical programs as well as global expansion of IAG’s operations.
‘We warmly welcome the new team members, whose passion to quality and science and commitment to achieving and exceeding targets resonate incredibly well with the rest of the organization’, said Dr. Olga Kubassova, IAG’s CEO.
‘As the team growth, we look forward to exciting 2019 and anticipate rapid growth both in Europe and USA,’ add Dr Christophe Berthoux, chairman of IAG.
Both, Michael and Sébastien start in January 2019 and will be supporting IAG’s global clinical research programs and operations.
IAG is a strategic partner to bio-pharmaceutical companies maximizing chances to succeed in taking break-through therapies from phase I to the patient. We broadly leverage our expertise in medical imaging, AI based analytics, DYNAMIKA, the cloud platform and risk sharing business model to enable faster fact-based decisions on drug efficacy, optimised control over the trial performance and study finances. www.ia-grp.com